Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F2KN
|
|||
| Drug Name |
Dihydropyrimidinone derivative 3
|
|||
| Synonyms |
PMID25470667-Compound-Figure6-24
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BRISTOL-MYERS SQUIBB COMPANY
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mannoside acetylglucosaminyltransferase 2 (MGAT2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Mannoside acetylglucosaminyltransferase 2 (MGAT2) | Target's Patent Info | [1] | |
| KEGG Pathway | N-Glycan biosynthesis | |||
| Metabolic pathways | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Acyltransferase inhibitors: a patent review (2010-present).Expert Opin Ther Pat. 2015 Feb;25(2):145-58. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.